Treatment Advances in Digestive Disorders

Helicobacter pylori (H. pylori) infection is a typical infection which is the major cause of peptic ulcer disease and gastric cancer. Most people with H. pylori infection will never have any signs or symptoms. Diagnosis of this disease can be done using blood test, breath test, stool test, scope test. Treatment can be done using Proton pump inhibitors, Histamine (H-2) blockers, Bismuth subsalicylate. Non-steroidal anti-inflammatory drugs (NSAIDs) are among the most widely used drugs and their widespread use is associated with increased gastro-intestinal toxic effects such as ulceration, hemorrhage, perforation and death. Using of Lansoprazole in the prophylaxis of acid aspiration during elective surgery is one the advance treatment in Digestive diseases.

  • Helicobacter Pylori Treatment
  • Nonsteroidal anti-inflammatory drugs
  • Proton-pump inhibitors
  • Prophylaxis with Lansoprazole

Related Conference of Treatment Advances in Digestive Disorders

October 29-30, 2018

4th World Congress on Digestive & Metabolic Diseases

| San Francisco, California, USA
November 07-08, 2018

World Summit on Liver Cirrhosis and Hepatitis

Singapore
December 17-18, 2018

3rd World Liver Congress

Abu Dhabi, UAE
January 30-31, 2019

16th World Congress on Gastroenterology & Therapeutics

Bangkok, Thailand
March 04-05, 2019

20th World Congress on Gastroenterology

Berlin, Germany
June 17-18, 2019

World Liver Conference 2019

Columbus, Ohio, U.S.A
July 08-09, 2019

14th Euro-Global Gastroenterology Conference

Zurich, Switzerland
July 15-16, 2019

7th International Conference on Hepatology

Sydney, Australia
October 14-15, 2019

19th World Gastroenterologists Summit

Sydney, Australia

Treatment Advances in Digestive Disorders Conference Speakers

Recommended Sessions

Related Journals

Are you interested in